Other OTC Pharmaceuticals (Pharmacies) - Rwanda

  • Rwanda
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$7.92m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.80%, resulting in a market volume of US$8.66m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.55 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Rwanda is experiencing significant growth and development. Customer preferences in the market are shifting towards over-the-counter (OTC) pharmaceutical products. This can be attributed to the increasing awareness and importance of self-medication among consumers. With busy lifestyles and limited access to healthcare facilities, consumers are seeking convenient and affordable solutions for minor health issues. OTC pharmaceuticals provide a quick and accessible remedy for common ailments, such as cough, cold, and pain relief. Additionally, the growing middle class and rising disposable income levels in Rwanda have also contributed to the increased demand for OTC pharmaceutical products. Trends in the market indicate a rise in the number of pharmacies and drugstores across Rwanda. This can be attributed to the government's efforts to improve access to healthcare services in the country. The government has implemented policies and initiatives to promote the establishment of pharmacies in both urban and rural areas. This has resulted in increased competition among pharmacies, leading to a wider range of OTC pharmaceutical products available to consumers. Furthermore, technological advancements have also played a role in the growth of the market, with the emergence of online pharmacies and e-commerce platforms offering OTC pharmaceutical products. Local special circumstances in Rwanda have also contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has made significant progress in improving its healthcare infrastructure and expanding access to healthcare services. This has resulted in increased healthcare expenditure and a greater focus on preventive care. As a result, consumers are more proactive in managing their health and seeking OTC pharmaceutical products to address minor health issues. Additionally, the government has implemented regulations to ensure the quality and safety of OTC pharmaceutical products, further boosting consumer confidence in the market. Underlying macroeconomic factors, such as population growth and urbanization, have also influenced the development of the market. Rwanda has a young and growing population, which has led to increased demand for healthcare services and OTC pharmaceutical products. Urbanization has also played a role, as urban areas tend to have higher concentrations of pharmacies and drugstores, catering to the needs of the population. Furthermore, the government's focus on promoting economic growth and diversification has resulted in increased investment in the healthcare sector, driving the expansion of the Other OTC Pharmaceuticals (Pharmacies) market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Rwanda is experiencing growth and development due to shifting customer preferences, increasing competition among pharmacies, local special circumstances, and underlying macroeconomic factors. The market is expected to continue to expand as consumers seek convenient and affordable solutions for minor health issues, and the government continues to invest in improving healthcare infrastructure and access to healthcare services.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)